Houston, TX, United States of America

Jerzy Gumulka

This inventor holds 1 USPTO granted patent. Top assignee: Biospectrum, Inc.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerzy Gumulka. Retrieved from https://idiyas.com/inventor/jerzy-gumulka-14bojf3j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jerzy Gumulka

Introduction

Jerzy Gumulka is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the production of human interferon gamma and interleukin-2. His work has implications for medical research and therapeutic applications.

Latest Patents

Jerzy Gumulka holds a patent for a process titled "Human interferon gamma and interleukin-2." This innovative method involves chromatographic fractionation utilizing ion exchange and metal chelate chromatography. The process allows for the purification of interferon gamma and interleukin-2 from crude interferon obtained by mitogen induction of human white blood cells. He has 1 patent to his name.

Career Highlights

Gumulka is associated with Biospectrum, Inc., where he continues to advance his research and development efforts. His work at the company focuses on biotechnological innovations that can lead to improved health outcomes.

Collaborations

One of his notable coworkers is Jerzy Alexander Georgiades, with whom he has likely collaborated on various projects within the field.

Conclusion

Jerzy Gumulka's contributions to biotechnology, particularly through his patented processes, highlight the importance of innovation in medical research. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…